As of the market open today, cannabis investors can now get their very own piece of ABcann Global on the TSX Ventures Exchange.

ABcann Global's wholly-owned subsidiary, ABcann Medicinals received its production license from Health Canada in March 2014 and has since obtained a sales license. The company has also completed exports to Israel and Australia and has applied to begin exporting to Germany.  

Shares of ABcann Global (TSXV:ABCN) opened at $1.50 CAD and are trading around $1.13 CAD in midday trading. 

We'll be watching shares of ABcann Global throughout the market session to see how the company's first day of trading finishes out. 

Disclaimers:  

I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article.

This site has been designed for informational and educational purposes only and does not constitute an offer to sell nor a solicitation of an offer to buy any security which may be referenced upon the site. The services and information provided through this site are for personal, non-commercial, educational use and display. www.dailymarijuanaobserver.com does not provide investment advice through this site and does not represent that the securities or services discussed are suitable for any investor. Investors are advised not to rely on any information contained in the site in the process of making a fully informed investment decision.